tiprankstipranks
Trending News
More News >
Biogen (BIIB)
NASDAQ:BIIB
US Market

Biogen (BIIB) Income Statement

Compare
4,984 Followers

Biogen Income Statement

Last quarter (Q3 2025), Biogen's total revenue was $2.45B, a decrease of -0.45% from the same quarter last year. In Q3, Biogen's net income was $466.50M. See Biogen’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 9.68B$ 9.84B$ 10.17B$ 10.98B$ 13.44B
Gross Profit
$ 7.37B$ 7.30B$ 7.90B$ 8.87B$ 11.64B
Operating Expenses
$ 4.88B$ 5.20B$ 5.01B$ 6.08B$ 7.05B
Depreciation and Amortization
$ 673.20M$ 494.80M$ 518.40M$ 487.70M$ 457.20M
EBITDA
$ 3.00B$ 2.38B$ 3.54B$ 3.92B$ 5.11B
Operating Income
$ 2.49B$ 2.10B$ 2.89B$ 2.79B$ 4.59B
Other Income/Expenses
$ -584.30M$ -800.50M$ 705.30M$ -1.01B$ 459.80M
Pretax Income
$ 1.91B$ 1.30B$ 3.59B$ 1.78B$ 5.05B
Net Income
$ 1.63B$ 1.16B$ 3.05B$ 1.56B$ 4.00B
Per Share Metrics
Basic EPS
$ 11.20$ 8.02$ 20.97$ 10.44$ 24.86
Diluted EPS
$ 11.19$ 7.97$ 20.87$ 10.40$ 24.80
Weighted Average Shares Outstanding
145.70M 144.70M 145.30M 149.10M 160.90M
Weighted Average Shares Outstanding (Diluted)
145.90M 145.60M 146.00M 149.60M 161.30M
Currency in USD

Biogen Earnings and Revenue History